Skip to main content

Table 6 Prognostic factors for cancer-specific survival

From: Preoperative Master’s double two-step test may predict survival after lobectomy in patients with lung cancer

Variable

Univariate analysis

p value

Multivariate analysis

p value

Risk ratio (95% CI)

Risk ratio (95% CI)

Male

2.60 (0.89–9.39)

0.083

  

Age

1.07 (1.01–1.15)

0.026

1.09 (1.00–1.19)

0.045

PS 1, 2

0.600

  

Smoking history

1.81 (0.64–5.82)

0.266

  

CCI

1.24 (0.94–1.50)

0.113

  

Incomplete MDT

1.43 (0.22–5.25)

0.657

  

CEA level

1.15 (1.07–1.28)

 < 0.001

1.10 (1.02–1.25)

0.008

SUV max

1.14 (1.05–1.22)

0.004

1.05 (0.91–1.19)

0.475

Invasive component size

1.11 (1.04–1.20)

 < 0.001

1.03 (0.92–1.15)

0.550

Non-adenocarcinoma

4.71 (1.69–13.4)

0.004

1.44 (0.25–8.61)

0.681

Lymphatic invasion

8.35 (2.29–24.7)

0.003

4.15 (0.60–20.0)

0.134

Vascular invasion

7.31 (1.65–23.5)

0.013

2.62 (0.37–12.5)

0.297

STAS

1.99 (0.55–5.83)

0.267

  
  1. CI: confidence interval, PS: performance status, CCI: Charlson comorbidity index, MDT: Master’s double two-step test, CEA: carcinoembryonic antigen, SUV: standardized uptake value, STAS: spread through air spaces